Literature DB >> 25361818

Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Wouter N Leonhard1, Malu Zandbergen2, Kimberley Veraar2, Susan van den Berg1, Louise van der Weerd3, Martijn Breuning1, Emile de Heer2, Dorien J M Peters4.   

Abstract

In total, 1 in 1000 individuals carries a germline mutation in the PKD1 or PKD2 gene, which leads to autosomal dominant polycystic kidney disease (ADPKD). Cysts can form early in life and progressively increase in number and size during adulthood. Extensive research has led to the presumption that somatic inactivation of the remaining allele initiates the formation of cysts, and the progression is further accelerated by renal injury. However, this hypothesis is primarily on the basis of animal studies, in which the gene is inactivated simultaneously in large percentages of kidney cells. To mimic human ADPKD in mice more precisely, we reduced the percentage of Pkd1-deficient kidney cells to 8%. Notably, no pathologic changes occurred for 6 months after Pkd1 deletion, and additional renal injury increased the likelihood of cyst formation but never triggered rapid PKD. In mildly affected mice, cysts were not randomly distributed throughout the kidney but formed in clusters, which could be explained by increased PKD-related signaling in not only cystic epithelial cells but also, healthy-appearing tubules near cysts. In the majority of mice, these changes preceded a rapid and massive onset of severe PKD that was remarkably similar to human ADPKD. Our data suggest that initial cysts are the principal trigger for a snowball effect driving the formation of new cysts, leading to the progression of severe PKD. In addition, this approach is a suitable model for mimicking human ADPKD and can be used for preclinical testing.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  autosomal dominant polycystic kidney disease; genetic renal disease; polycystic kidney disease; renal injury; signaling

Mesh:

Substances:

Year:  2014        PMID: 25361818      PMCID: PMC4446864          DOI: 10.1681/ASN.2013080864

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  43 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis.

Authors:  P Darwin Bell; Wayne Fitzgibbon; Kelli Sas; Antine E Stenbit; May Amria; Amber Houston; Ryan Reichert; Sandra Gilley; Gene P Siegal; John Bissler; Mehmet Bilgen; Peter Cheng-te Chou; Lisa Guay-Woodford; Brad Yoder; Courtney J Haycraft; Brian Siroky
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

4.  Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease.

Authors:  Zlata Novalic; Annemieke M van der Wal; Wouter N Leonhard; Gudrun Koehl; Martijn H Breuning; Edward K Geissler; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 10.121

5.  Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption.

Authors:  Neeraj Sharma; Erik B Malarkey; Nicolas F Berbari; Amber K O'Connor; Gregory B Vanden Heuvel; Michal Mrug; Bradley K Yoder
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

6.  Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.

Authors:  Ayumi Takakura; Erik A Nelson; Nadeem Haque; Benjamin D Humphreys; Kambiz Zandi-Nejad; David A Frank; Jing Zhou
Journal:  Hum Mol Genet       Date:  2011-08-05       Impact factor: 6.150

7.  mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease.

Authors:  Franck Belibi; Kameswaran Ravichandran; Iram Zafar; Zhibin He; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

8.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

9.  Detected renal cysts are tips of the iceberg in adults with ADPKD.

Authors:  Jared J Grantham; Sumanth Mulamalla; Connor J Grantham; Darren P Wallace; Larry T Cook; Louis H Wetzel; Timothy A Fields; K T Bae
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 8.237

10.  Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.

Authors:  Ming Ma; Xin Tian; Peter Igarashi; Gregory J Pazour; Stefan Somlo
Journal:  Nat Genet       Date:  2013-07-28       Impact factor: 38.330

View more
  26 in total

1.  Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Authors:  Leslie S Gewin; Megan E Summers; Julie W Harral; Christa F Gaskill; Stellor Nlandu Khodo; Surekha Neelisetty; Timothy M Sullivan; Katharina Hopp; J Jeffrey Reese; Dwight J Klemm; Valentina Kon; Kevin C Ess; Wei Shi; Susan M Majka
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

Review 2.  Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.

Authors:  Wouter N Leonhard; Hester Happe; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

3.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

Review 4.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

Review 5.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

6.  Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Steven J Kunnen; Anna J Plugge; Arja Pasternack; Sebastian B T Jianu; Kimberley Veraar; Fatiha El Bouazzaoui; Willem M H Hoogaars; Peter Ten Dijke; Martijn H Breuning; Emile De Heer; Olli Ritvos; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2016-03-28       Impact factor: 10.121

7.  Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice.

Authors:  Yang Yang; Meihan Chen; Jie Zhou; Jiayi Lv; Shuwei Song; LiLi Fu; Jiejian Chen; Ming Yang; Changlin Mei
Journal:  J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 10.121

Review 8.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

9.  Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.

Authors:  Archana Raman; Stephen C Parnell; Yan Zhang; Gail A Reif; Yuqiao Dai; Aditi Khanna; Emily Daniel; Corey White; Jay L Vivian; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-17

10.  The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.

Authors:  Corinne Antignac; James P Calvet; Gregory G Germino; Jared J Grantham; Lisa M Guay-Woodford; Peter C Harris; Friedhelm Hildebrandt; Dorien J M Peters; Stefan Somlo; Vicente E Torres; Gerd Walz; Jing Zhou; Alan S L Yu
Journal:  J Am Soc Nephrol       Date:  2015-05-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.